Amarantus Bioscience Holdings Inc (AMBS)

[21ZNA9]

Quarterly losses up nearly 400% year to year.


Amarantus reported a net loss for the third quarter of 2013 of $2,025,512 or $0.00 per share as compared to a net loss of $564,379 or $0.00 per share for the third quarter of 2012. The Company reported a net loss for the nine months ended September 20, 2013 of $5,783,685 or ($0.01) per share as compared to a net loss of $2,871,643 or ($0.03) per share for the same period in 2012.